ArticleLeukemia2010

Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 patients with MDS or secondary AML.

F Dicker et al.PubMed ↗Publisher ↗

No numbers read from the abstract.